The impact of global vigilance reporting requirements on the quality of dialysis products and services

  • Pamela McDonnell
  • Richard S. Thuma
Part of the Developments in Nephrology book series (DINE, volume 39)


In the past several decades, increased regulation of the drug and device industry has significantly impacted the way manufacturers develop, manufacture, market and monitor medical products. As the distribution of medical products expands globally, so also the need for industry and regulators to understand product safety and performance on a world-wide basis. The resulting depth and specificity of quality system requirements have led to significant demands on both industry and governmental agencies.


Medical Device Reporting Requirement Periodic Safety Update Report Global Procedure Durable Medical Equipment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    O’Leary D. Quality assessment: moving from theory to practice. J Am Med Assoc 1988; 260:1760.CrossRefGoogle Scholar
  2. 5.
    Sauer F. A new and fast drug approval system in Europe. Drug Inf J 1997; 31:1–6.Google Scholar
  3. 6.
    Jones K. Wider perspectives of European medicines control. Drug Inf J 1996; 30:1–7.Google Scholar

Copyright information

© Kluwer Academic Publishers. 1999

Authors and Affiliations

  • Pamela McDonnell
  • Richard S. Thuma

There are no affiliations available

Personalised recommendations